Yunji Soars on Narrower Loss; Ginkgo Bioworks, Xcel Energy Downgraded
- June 02nd, 2023
- 185 views
Yunji Inc. (Nasdaq: YJ) experienced a significant surge in its stock price as the company reported a narrower loss in its financial results.
In the first quarter of 2023, Yunji recorded a net loss of RMB22.9 million (US$3.3 million), representing a substantial improvement of 37.9% compared to the net loss of RMB36.9 million in the same period of the previous year.
$YJ was trading at $0.40 in pre-market, up $0.18 (+88.59%)
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) faced a downgrade in its rating from Neutral to Sell by Goldman Sachs, accompanied by a significant decrease in its price target from $3 to $1.25.
During pre-market, $DNA was trading at $1.60, down $0.07 (-4.46%).
Similarly, Xcel Energy Inc. (Nasdaq: XEL) experienced a downgrade in its rating from Overweight to Neutral by JP Morgan, along with a lowered price target from $79 to $68. Wolfe Research also downgraded XEL from Outperform to Peer Perform.
$XEL was trading at $62.18 in pre-market, showing a decrease of $1.37 (-2.16%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
CSX, VinFast Auto, and Crown Castle's Earnings Preview
April 14th, 2024Earnings Spotlight: McCormick, TD SYNNEX, and GameStop Set to Report
March 23rd, 2024Upcoming Earnings: Adobe, Ulta Beauty, and Smartsheet Under the Lens
March 10th, 2024
Member Login